Followers | 43 |
Posts | 6094 |
Boards Moderated | 1 |
Alias Born | 04/12/2021 |

Thursday, November 25, 2021 12:17:36 PM
Market Cap Market Cap
599,375,904
11/24/2021
Authorized Shares
Not Available
Outstanding Shares
124,094,390
07/31/2021
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
Not Available
Par Value
Not Available
https://www.otcmarkets.com/stock/NAUT/security
my posts are always theory and not financial advice
Liked By
Spread the love. Be the first to like this post!
Recent NAUT News
- Nautilus Biotechnology to Participate in Upcoming September Investor Conferences • GlobeNewswire Inc. • 09/06/2023 11:30:00 AM
- Nautilus Biotechnology to Participate in Upcoming August Investor Conferences • GlobeNewswire Inc. • 08/04/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2023 08:03:16 PM
- Nautilus Biotechnology Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/02/2023 11:30:00 AM
- Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 • GlobeNewswire Inc. • 07/11/2023 01:23:03 PM
- Nautilus Biotechnology to Participate in Upcoming June Investor Conferences • GlobeNewswire Inc. • 05/24/2023 12:05:00 PM
- Nautilus Biotechnology Reports First Quarter 2023 Financial Results • GlobeNewswire Inc. • 05/02/2023 10:30:00 AM
- Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023 • GlobeNewswire Inc. • 04/18/2023 08:05:00 PM
- Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference • GlobeNewswire Inc. • 03/23/2023 12:00:00 PM
- Nautilus Biotechnology Announces “First Access Challenge” Winners • GlobeNewswire Inc. • 03/07/2023 01:00:00 PM
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results • GlobeNewswire Inc. • 02/23/2023 11:05:00 AM
- Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/21/2023 01:00:00 PM
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 • GlobeNewswire Inc. • 01/26/2023 01:00:00 PM
- Nautilus Biotechnology Expands to San Diego • GlobeNewswire Inc. • 01/26/2023 12:45:00 PM
- Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
- Nautilus Biotechnology Launches “First Access Challenge” • GlobeNewswire Inc. • 11/16/2022 01:00:00 PM
- Nautilus Biotechnology Reports Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/01/2022 10:05:00 AM
- Nautilus Biotechnology to Announce Third Quarter 2022 Financial Results on November 1, 2022 • GlobeNewswire Inc. • 10/05/2022 12:00:00 PM
- Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit • GlobeNewswire Inc. • 09/23/2022 12:00:00 PM
Green Egg to launch $150 million bond offer for quicklime products production kiln plant Sep 22, 2023 12:11 PM
Nate's Food Co. Announces Reverse Merger and Change of Control with JP Energy Group to Drive Global Expansion • NHMD • Sep 22, 2023 9:00 AM
Trio Petroleum Corp Provides Update on Testing of the HV-1 Discovery Well • TPET • Sep 21, 2023 9:38 AM
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM